Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Purasomes is a line of secretome-based aesthetic products developed by Dermoaroma, an Italian research and development company. The formulations are powered by proprietary AMPLEX Plus technology, which utilizes secretomes and exosomes derived from organic bovine colostrum. Each treatment typically contains 20 billion exosomes and 20 functional growth factors. The product line includes several specialized formulations: Purasomes NC150+ (Nutri Complex) for skin regeneration and collagen production, Purasomes SGC100+ (Skin Glow Complex) for skin vitality and complexion enhancement, and Purasomes HSC50+ for hair restoration. These products are designed to reset cellular activity and enhance the body's natural healing response, stimulating fibroblast formation and improving skin structure, strength, and elasticity. They are intended for aesthetic skin rejuvenation and are typically administered through in-clinic procedures such as microneedling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Purasomes.